In certain neuro-degenerative diseases likemultiple sclerosis (MS), the rate of brain atrophy can be measured by monitoring the brain parenchymal fraction (BPF) in such patients. The BPF is defined as the ratio of brain parenchymal volume (BPV, defined as the total volume of gray matter tissue, white matter tissue and other unidentified tissue) and intracranial volume (ICV, the total volume of the skull). It can be represented by the formula in equation 1: A complication with this measure is that the BPF is affected by the presence of edema in the brain, which leads to swelling and hence may obscure the true rate of brain atrophy. This leads to uncertainty when establishing “normal values” of BPF when analyzing different magnetic resonance...
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous sy...
MRI-derived rates of hippocampal atrophy may serve as surrogate markers of disease progression in mi...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...
In certain neuro-degenerative diseases likemultiple sclerosis (MS), the rate of brain atrophy can be...
In certain diseases, like Multiple Sklerosis and Alzheimer's disease, the progression of the disease...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Nowadays magnetic resonance imaging is used for anatomical assessment of human brain structures in n...
A detailed analysis procedure is described for evaluating rates of volumetric change in brain struct...
OBJECTIVE: To explore the potential usefulness of two new magnetic resonance imaging (MRI) analysis ...
Objectives: To present a method for generating reference maps of typical brain characteristics of gr...
Quantitative magnetic resonance imaging has the major advantage that it handles absolute measurement...
Magnetic resonance imaging is a very useful tool to investigate a broad variety of pathologies on a ...
The use of standard brain atlases is well established in the MR community, but none of the commonly ...
Brain volume loss, or atrophy, has been proven to be an important characteristic of neurological dis...
Background Multiple sclerosis (MS) is an autoimmune disease characterised by inflammatory damage to ...
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous sy...
MRI-derived rates of hippocampal atrophy may serve as surrogate markers of disease progression in mi...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...
In certain neuro-degenerative diseases likemultiple sclerosis (MS), the rate of brain atrophy can be...
In certain diseases, like Multiple Sklerosis and Alzheimer's disease, the progression of the disease...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Nowadays magnetic resonance imaging is used for anatomical assessment of human brain structures in n...
A detailed analysis procedure is described for evaluating rates of volumetric change in brain struct...
OBJECTIVE: To explore the potential usefulness of two new magnetic resonance imaging (MRI) analysis ...
Objectives: To present a method for generating reference maps of typical brain characteristics of gr...
Quantitative magnetic resonance imaging has the major advantage that it handles absolute measurement...
Magnetic resonance imaging is a very useful tool to investigate a broad variety of pathologies on a ...
The use of standard brain atlases is well established in the MR community, but none of the commonly ...
Brain volume loss, or atrophy, has been proven to be an important characteristic of neurological dis...
Background Multiple sclerosis (MS) is an autoimmune disease characterised by inflammatory damage to ...
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous sy...
MRI-derived rates of hippocampal atrophy may serve as surrogate markers of disease progression in mi...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...